Jinghua Pharmaceutical Group Co., Ltd.

002349.SZ

002349.SZJinghua Pharmaceutical Group Co., Ltd. CN flag

Shenzhen

7.07

CNY

-0.02

(-0.28%)

0.25EPS

28.28P/E

5.74BMarket Cap

May 16Next Earn

Upgrade to Unlock Non-US CompaniesTo view real-time data and analysis of companies outside of the United States, upgrade your account to our premium subscription.

Upgrade

ISIN

CNE100000L14

Return %

Stock

S&P500

-10.39

8.32

-59.06

43.81

30.93

96.82

Use logarithmic scale

	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	TTM
Revenue per Share	1.11	1.22	0.96	0.99	1.05	1.33	1.63	1.42	1.57	1.67	1.93	1.86	1.72	1.72
Basic EPS, GAAP	0.08	0.06	0.07	0.1	0.2	0.21	0.28	-0.48	0.14	0.2	0.26	0.3	0.26	0.25
Free Cash Flow per Basic Share	-0.19	-0.19	0.03	-0.17	0.12	-0.43	-0.09	0.04	0.26	0.28	0.36	0.32	0.34	-0.03
Dividend per Share	0.02	0.03	0.02	0.04	0.04	0.08	0.07	0.07	0.02	0.05	0.07	0.08	0.09	0.09
Book Value per Share	0.58	0.61	0.76	0.66	0.94	1.57	1.78	1.29	1.41	1.55	1.71	1.91	2.06	2.14
Tangible Book Value per Share	0.95	1	2.28	1.88	1.81	2.23	2.27	2.2	2.66	2.77	2.94	3.16	3.35	3.44
Basic Weighted Avg Shares	600	600	600	785	840	840	833	814	814	814	814	814	814	814
Sales/Revenue/Turnover	665	733	578	780	881	1,121	1,355	1,157	1,281	1,358	1,573	1,512	1,402	1,398
Operating Margin (%)	6.99	6.92	8.25	11.32	19.98	24.43	23.53	11.66	19.66	14.11	14.97	20.55	18.61	18.53
Depreciation Expense	17	25	40	46	60	64	78	81	84	102	110	85	77	- -
Net Income, GAAP	49	36	39	78	165	175	230	-394	111	161	212	248	213	204
Effective Tax Rate (%)	17.31	5.02	20.48	15.39	14.12	12.22	9.84	- -	56.19	21.76	15.16	16.14	15.63	15.65
Profit Margin (%)	7.4	4.86	6.83	10.01	18.72	15.64	16.95	-34.01	8.66	11.83	13.49	16.38	15.17	14.57
Working Capital	288	264	944	787	655	918	745	548	891	992	1,334	1,624	1,519	1,604
LT Debt	- -	- -	3	1	- -	240	180	220	125	4	1	- -	- -	- -
Total Equity	715	742	1,535	2,234	2,303	2,647	2,695	2,148	2,487	2,570	2,624	2,804	2,957	3,031
Return on Invested Capital (%)	5.59	6.19	3.05	3.72	6.47	9.12	9.5	- -	4.3	5.73	7.85	10.06	7.76	7.28
Return on Capital (%)	11.33	6.9	6.73	9.91	17.7	11.22	9.73	- -	10.99	10.57	12.72	12.37	8.94	8.24
Return on Common Equity (%)	17.65	9.97	9.61	16	25.15	16.65	16.43	-31.15	10.1	13.32	16	16.8	13.14	12.1

Capital Structure

•

in mil. unless spec.

Working Capital

•

in mil. unless spec.

Growth Rates

FRC

•

in mil. unless spec.

(avg. rate of change)	10 years	5 years	1 year
Sales/Revenue/Turnover	10.29%	4.28%	-7.25%
Net Income, GAAP	-7.38%	-9.76%	-14.15%
Free Cash Flow	-112.8%	126.53%	6.53%
Total Cash Common Dividend	33.98%	22.75%	14.49%
Total Equity	7.87%	6.71%	5.45%

Growth Rates

•

in mil. unless spec.

Quarterly Revenue

•

in mil. unless spec.

Quarterly Earnings Per Share

•

in mil. unless spec.

Quarterly Dividends Per Share

•

in mil. unless spec.

Company Description

CEO: Mr. Yunzhong Zhou
Full Time Employees: 1,493
Sector: Healthcare
Industry: Drug Manufacturers - Specialty & Generic
Address: No 2-02#, Xrd Between 3 Haibin Rd & 2 To Nantong People's Republic of China 226407
IPO Date: Feb 3, 2010
Website: jinghuapharm.com
Similar Companies: Cannasouth Limited (CBD.NZ)
Molecule Holdings Inc. (MLCL.CN)
Torrent Pharmaceuticals Limited (TORNTPHARM.NS)
Aprogen pharmaceuticals,Inc. (003060.KS)
Chemesis International Inc. (CADMD)
BellRock Brands Inc. (DXBRF)
Business: Jinghua Pharmaceutical Group Co., Ltd. engages in the research and development, manufacture, and sale of APIs and pharmaceutical intermediates in China. Its primary products include Phenylbutazone, Primidone, Phenobarbital, Fluorouracil, Propylthiouracil, Piroxicam, and Flucytosine APIs. The company was formerly known as Nantong Jinghua Pharmaceutical Co., Ltd. Jinghua Pharmaceutical Group Co., Ltd. was founded in 1957 and is based in Nantong, China.

	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	TTM
Revenue per Share	1.11	1.22	0.96	0.99	1.05	1.33	1.63	1.42	1.57	1.67	1.93	1.86	1.72	1.72
Basic EPS, GAAP	0.08	0.06	0.07	0.1	0.2	0.21	0.28	-0.48	0.14	0.2	0.26	0.3	0.26	0.25
Free Cash Flow per Basic Share	-0.19	-0.19	0.03	-0.17	0.12	-0.43	-0.09	0.04	0.26	0.28	0.36	0.32	0.34	-0.03
Dividend per Share	0.02	0.03	0.02	0.04	0.04	0.08	0.07	0.07	0.02	0.05	0.07	0.08	0.09	0.09
Book Value per Share	0.58	0.61	0.76	0.66	0.94	1.57	1.78	1.29	1.41	1.55	1.71	1.91	2.06	2.14
Tangible Book Value per Share	0.95	1	2.28	1.88	1.81	2.23	2.27	2.2	2.66	2.77	2.94	3.16	3.35	3.44
Basic Weighted Avg Shares	600	600	600	785	840	840	833	814	814	814	814	814	814	814
Sales/Revenue/Turnover	665	733	578	780	881	1,121	1,355	1,157	1,281	1,358	1,573	1,512	1,402	1,398
Operating Margin (%)	6.99	6.92	8.25	11.32	19.98	24.43	23.53	11.66	19.66	14.11	14.97	20.55	18.61	18.53
Depreciation Expense	17	25	40	46	60	64	78	81	84	102	110	85	77	- -
Net Income, GAAP	49	36	39	78	165	175	230	-394	111	161	212	248	213	204
Effective Tax Rate (%)	17.31	5.02	20.48	15.39	14.12	12.22	9.84	- -	56.19	21.76	15.16	16.14	15.63	15.65
Profit Margin (%)	7.4	4.86	6.83	10.01	18.72	15.64	16.95	-34.01	8.66	11.83	13.49	16.38	15.17	14.57
Working Capital	288	264	944	787	655	918	745	548	891	992	1,334	1,624	1,519	1,604
LT Debt	- -	- -	3	1	- -	240	180	220	125	4	1	- -	- -	- -
Total Equity	715	742	1,535	2,234	2,303	2,647	2,695	2,148	2,487	2,570	2,624	2,804	2,957	3,031
Return on Invested Capital (%)	5.59	6.19	3.05	3.72	6.47	9.12	9.5	- -	4.3	5.73	7.85	10.06	7.76	7.28
Return on Capital (%)	11.33	6.9	6.73	9.91	17.7	11.22	9.73	- -	10.99	10.57	12.72	12.37	8.94	8.24
Return on Common Equity (%)	17.65	9.97	9.61	16	25.15	16.65	16.43	-31.15	10.1	13.32	16	16.8	13.14	12.1

Year	Q1	Q2	Q3	Q4	FY
2023	416	379	324	392	1,512
2024	367	353	325	357	1,402
2025	364	- -	- -	- -	- -

	Sep'24	Dec'24	Mar'25
Total Current Assets	2,074	1,844	1,930
Accounts Receivable, Net	296	291	312
Cash, Cash Equivalents & STI	1,339	1,119	1,183
Inventories	294	270	272
Total Current Liabilities	306	326	326
Payables & Accruals	- -	- -	- -
ST Debt	16	11	10
Deferred Revenue	- -	- -	- -

	Sep'24	Dec'24	Mar'25
ST Debt	16	11	10
LT Borrowings	- -	- -	- -
LT Finance Leases	- -	- -	- -
Preferred Equity and Hybrid Capital	- -	- -	- -
Shares Outstanding	814	814	814
Market Capitalization	6,514	6,229	5,888

Year	Q1	Q2	Q3	Q4	FY
2023	0.11	- -	- -	- -	0.3
2024	0.09	- -	- -	- -	0.26
2025	0.08	- -	- -	- -	- -

Jinghua Pharmaceutical Group Co., Ltd.

Growth Rates

(avg. rate of change)

Company Description

Growth Rates

(avg. rate of change)

Quarterly Revenue

Year

Capital Structure

Working Capital

Quarterly Dividends Per Share

Year

Quarterly Earnings Per Share

Year